Inoue, Noriyuki

Inoue, Noriyuki

Dr. Noriyuki Inoue graduated from University of Tsukuba with a Master’s degree in 2002. After graduation, he entered at Tokyo New Drug Research Laboratories, Kowa company, Ltd. Thereafter, he was on loan to the laboratory of Prof. Nobuhiro Yamada and Prof. Hitoshi Shimano in University of Tsukuba. He studied on dyslipidemia, obesity, hypertension and diabetes for 4 years. He investigated lipid synthesis transcription factor SREBP, especially relation between SREBP and p21WAF1/CIP1. Additionally, He revealed and p21WAF1/CIP1 had an important role for obesity and insulin resistance.He could reveal thedirect interaction with lipid synthesis and cell growth, and establish the new concept that metabolic disorder might be associated with cell growth protein. Thorough these works, he could publish some papers and gain doctoral degree.
At his company, he could establish the methods of insulin secretion screening system in some kinds of insulin secreted cell line. He has evaluated the treatment effects of anti-diabetes compounds using type 2 diabetic models, ob/ob, db/db, KKAy, diet-induced obesity mice and ZDF rats or so. He has kept researching the therapy drugs for metabolic disorder, especially diabetes over ten years.
He joined CICS in March, 2013. He has kept focusing on Diabetes field for new anti-diabetic drugs in CICS.

Publications

Show